Tweet
Prim Care Diabetes. 2019 Sep 30. pii: S1751-9918(19)30327-4. doi: 10.1016/j.pcd.2019.09.004. [Epub ahead of print] Vaccination adherence to influenza, pneumococcal and hepatitis B virus in adult type 1 diabetes mellitus patients.
Moreno-Fern?ndez J1, Garc?a-Seco JA2, Rodrigo EMO3, Segura AMS2, Garc?a-Seco F4, Mu?oz-Rodr?guez JR5.
Author information
1 Endocrinology and Nutrition Department, Ciudad Real University Hospital, Ciudad Real, Spain. Electronic address: jmorenof@sescam.jccm.es. 2 Endocrinology and Nutrition Department, Ciudad Real University Hospital, Ciudad Real, Spain. 3 Ciudad Real Medicine School, Castilla-La Mancha University, Ciudad Real, Spain. 4 C?rdoba Medicine School, C?rdoba University, C?rdoba, Spain. 5 Translational Research Unit, Ciudad Real University Hospital, Ciudad Real, Spain.
Abstract
AIM:
To document adherence to influenza, pneumococcal and hepatitis B virus (HBV) vaccination programme in adult type 1 diabetes mellitus (T1DM) patients.
MATERIALS AND METHODS:
Observational retrospective study using data obtained from computerized clinical records. We contacted all adult T1DM registered in our database from a tertiary diabetes care hospital. Primary efficacy outcome was to describe influenza, pneumococcal and HBV vaccination status.
RESULTS:
Three hundred patients were analyzed (male 53%). Mean age was 40.0?14.4years and T1DM duration was 19.7?11.8years. Thirty-five percent of the patients had complementary indications for studied vaccines. Adherence to vaccination program for influenza, pneumococcal and HBV was achieved by 55%, 18% and 17% of the patients, respectively. Only 3% of the subjects were vaccinated against the three microorganisms. Predictor of correct vaccination were: age, shorter diabetes duration, insulin pump treatment, better diabetes control and being a health professional. We detected 17 sick leaves, 127 lost working days and 3 hospitalizations due to flue during the follow-up.
CONCLUSIONS:
The uptake of recommended vaccinations against influenza, pneumococcal and HBV in adult T1DM patients was below desirable levels. A special effort is required to all health professionals to implement immunization among adult people with T1DM. Clinical Trials NCT03478254.
Copyright ? 2019 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
KEYWORDS:
HBV; Influenza; Pneumococcal; Type 1 diabetes; Vaccination
PMID: 31582202 DOI: 10.1016/j.pcd.2019.09.004